SAB Biotherapeutics Inc reports results for the quarter ended in December - Earnings Summary

SAB Biotherapeutics

02/04/2024 23:47

* SAB Biotherapeutics Inc  SABS.OQ  reported a quarterly
adjusted
loss of $3.38​​ per share for the quarter ended in December,
lower than the same quarter last year, when the company reported
EPS of -20 cents.  The mean expectation of three analysts for
the quarter was for a loss of 62 cents per share. Wall Street
expected results to range from -64 cents to -60 cents per share.
    * Revenue was $305.00 thousand​; analysts expected zero. 
    * SAB Biotherapeutics Inc's reported EPS for the quarter was
a
loss of $3.38​.
    * The company reported a quarterly loss of $22.86 million.
    * SAB Biotherapeutics Inc shares had fallen by 5.5% this
quarter and lost 37.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 3.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for SAB
Biotherapeutics Inc is $18.00 
This summary was machine generated from LSEG data April 2 at
10:47 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.62          -3.38          Missed
 Sep. 30 2023      -1.17          -1.00          Beat
 Jun. 30 2023      -1.45          -1.40          Beat
 Mar. 31 2023      -0.80          -1.50          Missed